ABCD Announcements Archive
Dr. Karen Adamson
On 11/12/16, the Scottish Government announced an additional £10 million funding for Type 1 diabetes. The funding is to increase pump provision over the next 5 years and provide CGM to priority…
Professor Jonathan Valabhji
As mentioned in Rob Gregory’s excellent Christmas Chair’s bulletin (See HERE), the manufacturers of Lucozade have recently given notice of their intentions to reduce its glucose content. The timing…
Dr. Robert Gregory
The next round of applications by NHS Trusts for Chief Registrars is open. Please encourage your trusts to bid, and for your extremely talented SpRs to apply for such posts! Click on the…
Dr. Robert Gregory
The wait is over! NHS England has advised that the Diabetes Call to Bid has now been published. The closing date for bids is 18 January. Note there is a new requirement to those…
Professor Gerry Rayman
The Diabetes UK Diabetes Specialist Nurse survey was launched in March 2016 to help us gain an understanding of the state of diabetes specialist nursing in 2016 and explore what change is needed to…
Dr. Emma Bingham
Good preparation for pregnancy in women with diabetes is well recognised to improve outcomes for mother and baby. So it is with some concern that we read in the recent National Diabetes in Pregnancy…
Professor Umesh Dashora
ABCD has produced a position statement on the risk of diabetic ketoacidosis associated with the use of sodium-glucose cotransporter-2 inhibitors. The key messages are shown below:
The use of SGLT-2…
Associate Professor Russell Drummond
The EASD in Munich was notable for two Endobarrier related events. There was a presentation of data on well over 200 patients from the German Endobarrier registry which confirmed the efficacy of this…
Dr. Robert Gregory
NHS England has announced in its planning guidance for 2017-2019 an investment of £40 million per year for at least two years for diabetes. Details of how to bid for a share of this have yet to…
Dr. Piya Sen Gupta
http://buff.ly/2d0OTaB: On 12 June 2016 the 1-year results of the REVISE-Diabesity research study of Endobarrier treatment, including an assessment of the impact on 10-year cardiovascular risk, were…
Dr. Robert Gregory
Click HERE to read the report from ABCD (Diabetes Care) Ltd committee chairman, Dr Rob Gregory
Dr. Mahender Yadagiri
See: https://youtu.be/y1zm0Scq6YM. On 3 June 2016 the first patient in the ABCD Endobarrier in obstructive sleep apnoea (End-OSA study) was started on her Endobarrier treatment. The…